CATX Perspective Therapeutics, Inc.

AMEX
$0.75

Perspective Therapeutics, Inc. (CATX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 5 buyers in the last 30 days 5 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
5
10 transactions
Insiders selling
0
0 transactions
Purchases
$175.4K
206,648 shares
Sales
$0
0 shares
Net activity
$175.4K
purchases less sales

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 18, 2026 , by Williamson Robert F III .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Williamson Robert F III Director Buy 15,000 $0.80 $12.0K 68,473
Williamson Robert F III Director Buy 25,000 $0.84 $21.0K 53,473
Morich Frank Director Buy 15,000 $0.94 $14.0K 30,000
Puhlmann Markus Chief Medical Officer Buy 35,000 $0.84 $29.6K 178,542
Williamson Robert F III 2 fills Director Buy 24,898 $0.84 $20.9K 115,271
Woods Lori A Director Buy 23,750 $0.84 $20.0K 28,557
Morich Frank Director Buy 15,000 $1.00 $15.0K 15,000
Spoor Johan M. Chief Executive Officer Buy 47,000 $0.81 $37.9K 106,383
Puhlmann Markus Chief Medical Officer Buy 6,000 $0.83 $5.0K 143,542

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.